Vaxil Bio Ltd. (VXL)
Market Closed
7 Aug, 20:00
TSX-V 
OTC PINK Primary TSX-V CA$
0. 17
0
0%
CA$
397.24K Market Cap
- P/E Ratio
- Div Yield
1,384 Volume
0 Eps
CA$ 0.17
Previous Close Want to track VXL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vaxil Bio Ltd. (VXL) Statistics
Valuation metrics
Market Cap 397.24K
Enterprise value 110.44K
Trailing P/E (ttm) 1.22
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.51
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.5
Overview
Shares outstanding 2.74M
Float 2.59M
Shares short 6
% Held by insiders 0.06%
% Held by institutions -
Average volume (10 days) 597
Average volume (90 days) 581
Price summary
52-Week low 0.13
52-Week high 0.29
Beta -1.24
50-Day moving average 0.17
200-Day moving average 0.18
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:50
Last split Date 15 May 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 30 Sep 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets 0.38%
Return on equity 0.5%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -94K
Diluted EPS (ttm) 0.12
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 447K
Total cash per share (mrq) 0.13
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 16.92%
Book value per share (mrq) 0.32
Cash Flow
Cash flow statement -213K
Levered free cash flow (LFCF) -65.62K
